These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10810634)

  • 1. Design and testing of ribozymes for cancer gene therapy.
    Norris JS; Hoel B; Voeks D; Maggouta F; Dahm M; Pan W; Clawson G
    Adv Exp Med Biol; 2000; 465():293-301. PubMed ID: 10810634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening effective target sites on mRNA: a ribozyme library approach.
    Unwalla HJ; Rossi JJ
    Methods Mol Biol; 2012; 848():329-36. PubMed ID: 22315078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of ribozymes for gene therapy.
    Sullivan SM
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
    Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-gene therapy: the use of ribozymes to inhibit gene function.
    Couture LA; Stinchcomb DT
    Trends Genet; 1996 Dec; 12(12):510-5. PubMed ID: 9257533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
    Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
    Wiechen K; Zimmer C; Dietel M
    Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of ribozymes.
    Kijima H; Ishida H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
    Pharmacol Ther; 1995; 68(2):247-67. PubMed ID: 8719970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and function of triplex hairpin ribozymes.
    Aquino-Jarquin G; Rojas-Hernández R; Alvarez-Salas LM
    Methods Mol Biol; 2010; 629():323-38. PubMed ID: 20387159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
    Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
    Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.
    Mistry SJ; Benham CJ; Atweh GF
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):41-9. PubMed ID: 11258620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
    Ivanov SA; Vauléon S; Müller S
    FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme.
    Chen S; Song CS; Lavrovsky Y; Bi B; Vellanoweth R; Chatterjee B; Roy AK
    Mol Endocrinol; 1998 Oct; 12(10):1558-66. PubMed ID: 9773979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs made of RNA: development and application of engineered RNAs for gene therapy.
    Drude I; Dombos V; Vauléon S; Müller S
    Mini Rev Med Chem; 2007 Sep; 7(9):912-31. PubMed ID: 17897081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme gene therapy: applications for molecular medicine.
    Lewin AS; Hauswirth WW
    Trends Mol Med; 2001 May; 7(5):221-8. PubMed ID: 11325634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.